Status:
COMPLETED
Etude PROTECT : Prognostic Role of Tapse Evaluation in Children's bronchioliTis
Lead Sponsor:
University Hospital, Bordeaux
Conditions:
Bronchiolitis
Viral
Eligibility:
All Genders
Up to 2 years
Phase:
NA
Brief Summary
In this prospective study, we aim to evaluate the association between an echocardiographic marker of right ventricular systolic function, the TAPSE (Tricuspid Annular Plane Systolic Excursion), and po...
Detailed Description
During the winter season, acute bronchiolitis is the leading cause of PICU admissions among children under the age of 2 years old, worldwide. Indeed, it is estimated that 10% of children hospitalized ...
Eligibility Criteria
Inclusion
- Infants under the age of 2
- Admitted to PICU with diagnosis of acute bronchiolitis (according to AAP criteria)
- Within the first 36h of PICU stay
Exclusion
- Patients suffering from Chronic Heart Disease, chronic respiratory disease (including bronchopulmonary dysplasia and excluding asthma)
- Impairment of echocardiographic window
Key Trial Info
Start Date :
October 18 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 9 2023
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT07209956
Start Date
October 18 2022
End Date
January 9 2023
Last Update
October 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bordeaux Hospital University
Bordeaux, France, 3300